XML 28 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Ownership Plans (Details) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
years
Dec. 31, 2012
Dec. 31, 2011
Feb. 28, 2013
Feb. 27, 2012
Feb. 28, 2011
Dec. 31, 2010
Dec. 31, 2013
Low end of range [Member]
Dec. 31, 2012
Low end of range [Member]
Dec. 31, 2011
Low end of range [Member]
Dec. 31, 2013
High end of range [Member]
Dec. 31, 2012
High end of range [Member]
Dec. 31, 2011
High end of range [Member]
May 31, 2011
2011 LTIP Plan [Member]
Dec. 31, 2013
Employee Stock [Member]
Dec. 31, 2013
Cost of products sold [Member]
Dec. 31, 2012
Cost of products sold [Member]
Dec. 31, 2011
Cost of products sold [Member]
Dec. 31, 2013
Selling General And Administrative [Member]
Dec. 31, 2012
Selling General And Administrative [Member]
Dec. 31, 2011
Selling General And Administrative [Member]
Dec. 31, 2013
Research and Development Expense [Member]
Dec. 31, 2012
Research and Development Expense [Member]
Dec. 31, 2011
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                
Total Fair Value of Market Based Awards - 2012 $ 8,000,000                                              
Unrecognized Compensation Cost - Stock Options 17,000,000                                              
Total fair value of market based awards - 2011 Awards   8,000,000                                            
Range of the target number of performance-based DSUs awarded               0.00%     150.00%                          
Fair value of the Free Cash Flow (FCF) performance awards 9,000,000 7,000,000                                            
Closing stock price at year end $ 12.02 $ 5.73                                            
Target payout of Free Cash Flows (FCF) performance awards 100.00%                                              
Stock Issued During Period, Shares, Employee Stock Purchase Plans 3,833,000 3,979,000 3,830,000                                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 37,339,000 36,593,000 33,576,000       33,284,000                                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 7 $ 7 $ 8       $ 9                                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 13,913,000 17,073,000 14,640,000                                          
Stock price on date of grant for market-based awards       7.39 6.28 7.16                                    
Measurement period - market based awards - 2012 Awards 3 years 3 years                                            
Measurement period - market based awards - 2011 Awards     3 years                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate - 2012 Awards 0.34% 0.38%                                            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 8 $ 6 $ 7                                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (10,307,000) (10,158,000) (10,344,000)                                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 8 $ 9 $ 10                                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (2,860,000) (3,898,000) (4,004,000)                                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value $ 7 $ 7 $ 6                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 44,892,000 54,881,000 60,921,000       60,374,000                                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,992,000 4,726,000 16,311,000                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (7,221,000) 0 (18,000)                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $ 8 $ 0 $ 7                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period (4,760,000) (10,766,000) (15,746,000)                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 21 $ 15 $ 12                                          
Stock-based compensation expense 105,000,000 108,000,000 128,000,000                         8,000,000 15,000,000 25,000,000 79,000,000 69,000,000 74,000,000 18,000,000 24,000,000 29,000,000
Common Stock, Shares Authorized 2,000,000,000 2,000,000,000                       146,000,000                    
Common Stock, Capital Shares Reserved for Future Issuance 242,000,000                                              
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense (29,000,000) (32,000,000) (34,000,000)                                          
Share-based compensation, net of tax benefit 76,000,000 76,000,000 94,000,000                                          
compensation expense, per share - basic $ 0.06 $ 0.05 $ 0.06                                          
compensation expense, per share - diluted $ 0.06 $ 0.05 $ 0.06                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 7.44 $ 6.23 $ 7.11                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 2.84 $ 2.60 $ 3.07                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 36.00% 43.00% 42.00%                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years 10 months 24 days 5 years 10 months 24 days 6 years 1 month 6 days                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum 0.89% 0.95% 1.16%                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 1.72% 1.15% 2.61%                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value 24,000,000 1,000,000 1,000,000                                          
Employee stock purchase plan, purchase price, range               $ 5.01 $ 4.82 $ 4.81 $ 7.96 $ 5.16 $ 6.22                      
Employee Stock Ownership Plan (ESOP), Compensation Expense 7,000,000 4,000,000 5,000,000                                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 12 $ 12 $ 13       $ 14                                  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 5 years 2 months 12 days                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 137,000,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 32,927,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $ 13                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term 4 years 3 months 18 days                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value 77,000,000                                              
Options expected to vest 11,433,000                                              
Options expected to vest, weighted average exercise price $ 7                                              
Options expected to vest, weighted average remaining contractual life 7 years 7 months 6 days                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value 58,000,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 44,360,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 12                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 5 years 1 month 6 days                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 135,000,000                                              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value 80,000,000 60,000,000 71,000,000                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate - 2011 Awards     1.10%                                          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                             35,000,000                  
Amount of employees total compensation eligible for GESOP purchase 10.00%                                              
Global Employee Stock Purchase Plan - Exercise Amount equivalent to 85% of Fair Market Value of Common Stock at beginning or end of each offering period (whichever is less) 85.00%                                              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                             8,000,000                  
Unrecognized Compensation Cost - Non-vested stock awards 166,000,000                                              
Unrecognized Compensation Cost $ 183,000,000                                              
weighted average remaining vesting period 1 year 4 months 25 days                                              
annualweightedaverageforfeiturerate 9.00%                                              
Common Stock, Capital Shares Reserved for Future Issuance - Not Issuable 50,000,000                                              
Nonqualified Options Vesting Period 4 years                                              
Nonqualified Options Contractual Life 10 years                                              
voting power of all classes of stock 10.00%                                              
Exercise price of the fair market value of our common stock on the date of grant 110.00%                                              
Qualified options expire over a period not to exceed 5 years                                              
Qualified options exercise price $ 0                                              
Qualified options vesting period 5